How long does it take to see results from Wegovy?

What happens in the first few weeks, and why the scales feel slow?

There's a persistent misconception that Wegovy should produce dramatic, rapid loss from the very first injection. It doesn't work that way, and expecting it to can lead people to give up too early.

Semaglutide works by activating GLP-1 receptors in the brain and gut, slowing how quickly the stomach empties and reducing appetite signals. But treatment starts at 0.25mg, a dose chosen to let your body adjust, not to drive weight loss. Appetite suppression tends to deepen as the dose increases over the following months, which is why the first four to eight weeks often feel modest.

What most people do notice early on is a shift in hunger patterns: meals feel filling sooner, the urge to snack between them fades, and portion sizes drift down without effort. That shift is the medicine working. The NHS tirzepatide and semaglutide medicines information describes this appetite effect clearly. If you want to understand how long before you see results from Wegovy, it helps to know that weight loss follows appetite change, it rarely precedes it. Patience in these early weeks matters more than most people realise.

If you're curious about how the semaglutide timeline compares across different formulations, the broader semaglutide results timeline covers that in detail.

When do results become clinically meaningful, and what does the trial data show?

The clearest signal in the evidence is that Wegovy's results accumulate over months, not days. In the STEP 1 trial, participants lost weight consistently from around week four through to week 68, with no single dramatic moment but a steady, compounding reduction.

By three months, average losses in the trial were already clinically meaningful, typically in the 5–8% range. By six months, many participants had passed the 10% threshold that carries documented cardiovascular and metabolic benefit. The 15% average figure that is most widely cited reflects the full 68-week course at the 2.4mg maintenance dose, and you can read more about what those figures mean in practice on our page covering results from Wegovy.

The higher 7.2mg dose (approved by the MHRA in January 2026 and available as a dedicated single-dose pen from April 2026) showed approximately 20.7% average weight loss over 72 weeks in subsequent trials, approaching the results seen with tirzepatide. For a detailed look at how long it takes to see results from Wegovy across the full course, including what to expect at each stage, our dedicated page covers this in depth.

NICE recommends semaglutide for a maximum of two years within an appropriate clinical setting, with a review point at six months: if weight loss is less than 5% at the highest tolerated dose by that stage, continuing is reconsidered. That six-month checkpoint is worth knowing about before you start. Pricing context, for those weighing up the full picture, is covered on the Wegovy sourcing and cost page.

Does everyone see results at the same pace?

No, and the variation is wider than many people expect. Several factors shape how quickly (and how much) weight changes on Wegovy.

Starting weight matters: someone with a higher BMI may see a larger absolute loss while the percentage figure looks similar to someone lighter. Dose reached matters considerably: people who tolerate escalation to 2.4mg (or 7.2mg) tend to see more substantial results than those who plateau at a lower dose because of side effects. Lifestyle factors run alongside the medicine rather than being replaced by it, the trial evidence was gathered alongside a reduced-calorie diet and increased physical activity, and that combination is part of the NHS England guidance on weight management injections.

Individual biology also plays a role. GLP-1 receptor sensitivity varies between people, and that affects response. A prescriber who reviews your progress regularly (as ours do before every repeat at nume) can help distinguish a normal slow build from a sign that something needs adjusting. The full Wegovy treatment guide covers how the dose schedule and monitoring work in practice.

When should you be concerned that results aren't coming?

If weight is completely unchanged after three months at the same dose, that's worth discussing with your prescriber rather than waiting until six months. It may simply mean you haven't yet reached the dose at which the medicine works best for you. It may also mean a lifestyle or adherence factor is offsetting the effect, something a clinical review can unpick.

A few things that aren't causes for concern: fluctuations on the scale week to week (normal, given water retention and other variables), a slower start than a friend on the same treatment (individual variation is real), and a brief stall after a dose increase while your body adapts. Our frequently asked questions address several of these practical points.

If you experience side effects that make it hard to stay on treatment (nausea, digestive discomfort, fatigue) that's also a prescriber conversation, not something to push through alone. Dose timing, meal choices and hydration can all make a difference, and your clinical team can advise. Speak to our prescribers if you'd like a clinical review of where you are in your treatment.